Results: 67

Montaje y estandarización para determinar colesterol inmune en suero humano
Montaje y estandarización para determinar \"colesterol inmune\" en suero humano

Rev. cuba. endocrinol; 11 (3), 2000
Se realizó este trabajo para montar y estandarizar un método con el cual evaluar la lipoproteína de baja densidad oxidada (LDLox) contenida en los inmunocomplejos, mediante la cuantificación del colesterol total presente en el precipitado de polietilenglicol denominado "colesterol inmune". Se obtuvo ...

Efecto de los proteoglicanos arteriales sobre la oxidación in vitro de LDL aislada de pacientes hipercolesterolémicos
Effect of arterial proteoglycans on in vitro oxidation of LDL isolated from hypercholesterolemic patients

Acta cient. venez; 51 (4), 2000
The interaction of LDL with extracellular matrix proteoglycan apparently contribute to the acumulation of apo B-lipoproteins in atherogenesis. Retention of LDL by intima proteoglycans appears to increase the residence time needed for their structural, hydrolytic and oxidative modification. If the rate of...

In vivo metabolism of alpha-tocopherol in lipoproteins and liver: studies on rabbits in response to acute cholesterol loading

Säo Paulo med. j; 116 (4), 1998
Objective: To investigate the transport of alpha-tocopherol in lipoproteins of rabbits under normal diet and under acute loading of cholesterol. Design: Two New Zealand White rabbits were fed (14)C-alpha-tocopherol acetate in a single oral dose and the recovery of radiolabel in lipoproteins and plasma wa...

Platelet aggregation and lipoprotein leves in a patient with familial hypercholesterolemia after sective LDL-apheresis

Säo Paulo med. j; 115 (3), 1997
Platelet aggregation was studied in a patient with familial hypercholesterolemia immediately after aphereis selective for low-density lipoprotein (LDL), a lipid-lowering procedure. This treatment reduced plasmatic levels of total and LDL-cholesterol, apo B, and triglyceride. Increased platelet aggregatio...

Validade da intervençäo medicamentosa sobre as hiperlipidemias primárias na prevençäo da doenç a aterosclerótica coronária
Value of drug therapy of primary hyperlipidemia in prevention of atherosclerotic coronary artery disease

Arq. bras. cardiol; 51 (1), 1988

Glicosaminoglicanos plasmáticos em portadores de coronariopatia e hiperlipidemia
Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia

Arq. bras. cardiol; 46 (5), 1986
Com o objetivo de verificar se as concentraçöes séricas de lípides sanguíneos influenciam quantitativa e/ou qualitativamente os glicosaminoglicanos (GAG) circulantes, os autores analisaram estas substâncias em 14 indivíduos hiperlipidêmicos (13 com hiperlipidemia mista e 1 com hipercolesterolemia...